News tagged with 'Drug Products'

A new class of diabetes drugs has shown promising results in a clinical trial conducted to help bring it to market. If approved, liraglutide would be the second GLP-1 diabetes medicine approved by the FDA for sale in the U.S. Byetta was the first.

Drug makers are suddenly eager to disclose their payments to doctors and researchers for consulting, and speaking services as a federal government disclosure act is close to becoming law. Consumers will have more information to make informed decisions about health care and influence.

A new study suggests pregnant women who get a flu shot a month before delivery will help to prevent most cases of influenza from developing during the first six months of their babies' lives.

Injuryboard is trying to raise the profile on federal pre-emption, the legal argument raised by vaccine makers to auto manufacturers to block your access to the courts.  Some in the business community believe its a good idea to streamline government and help corporations stay profitable.     

Allergan, maker of Botox Cosmetic, saw its stock rise today on news that Phase III of clinical trials shows the drug can be used to treat migraine sufferers.   The company will likely seek FDA approval for expanded use of Botox, despite the side effects.

Generally television networks compete for viewers, but in a rare cooperation, the Big Three had ten million viewers for their "Stand Up To Cancer" Telethon that raised $100 million. The money will go directly to research that will be shared among scientists and not to research and drugs that become the proprietary product of pharmaceutical giants.  

The FDA will now post quarterly reports of adverse drug reports coming in that the agency is looking into. Cymbalta is one of the drugs, along with revlimid, tysabri and 17 others that appear on the first quarterly report for the year. 

Use the cholesterol lowering drug Vytorin with caution - that's the advice of editors of a leading medical journal after published reports link the drug to cancer deaths in a three-study analysis that was supposed to put to rest any concerns. 

You've seen the ads featuring celebrities pitching prescription drugs, such as Sally Field for Boniva.  Five billion a year is spent on direct-to-customer ads on TV, radio and print. Now a new study says it doesn't necessarily translate into more sales for drug manufacturers.

When Merck & Co launched the Advantage study in 1999, it said it was testing the painkiller, Vioxx, alongside its competitor.  Internal company documents now show that the clinical trial was "masquarading as science" and was actually a marketing ploy designed to promote the use of Vioxx among doctors pre-market. Merck denies the allegations in this published study.

People taking the type 2 diabetes drug, Byetta received an FDA warning Monday after it was reported that two people taking the drug died and four others were recovering from pancreatitis. People on the drug with any pancreas problems should stop taking it.  

Drug maker Wyeth is taking its final appeal of Diana Levine's case all the way to the U.S. Supreme Court to overturn her $6 million verdict. Jurors agreed that Wyeth should have changed a drug label to make it safer- Wyeth says the label is approved by the FDA. 

An ethical debate is brewing over just how long someone should be dead before their organs are harvested.  Is brain dead, dead enough?  Or should the brain, heart and lungs have ceased functioning irreversibly for a period of time before organs are taken?  Is 75 seconds enough time? This emotional debate has both sides speaking out.

Human trials are underway to determine if a common chemotherapy drug, followed 24 hours later by an osteoporosis drug kills breast cancer tumors. In mice, the combination and timing of the drugs was more than 99 percent effective in halting breast tumors. 

U.S. health officials announced Tuesday that they have approved vaccines for the 2008-09 flu season that include new strains of the virus most likely to circulate this season.